The discovery of the “IFNα signature,” which refers to the augmented expression of a group of IFNα induced genes, in peripheral blood mononuclear cells (PBMCs) from active lupus patients further highlighted the essential role of type I IFNs in the disease (2, 3). Here, IFNA1 is linked to systemic lupus erythematosus.